Rani Therapeutics Holdings, Inc., was incorporated in Delaware on April 6, 2021. The company is a clinical-stage biotherapeutic company advancing technology to facilitate the development of oral biologics, which the company believes has the potential to transform medicine and improve treatment outcomes for patients. The company developed RaniPill capsules, the company's novel, proprietary and patented platform technology designed to replace subcutaneous or intravenous biological agents with oral administration. 

Expected P&L on Expiry

Key Stats

Pricing Model

About RANI20261016C1